Lateral septal PACAP signaling regulates stress and anxiety reactions

Severe and/or repeated stress exposure can lead to a number of maladaptive physiological and behavioral changes that contribute to psychiatric illnesses. Recent work indicates that the neuropeptide pituitary-adenylate-cyclase-activating-polypeptide (PACAP) plays an important role in stress-related psychopathologies relevant to depression and trauma-related disorders such as PTSD. However, the specific neural circuits that mediate PACAP effects on stress function are not fully understood. One candidate area is the lateral septum (LS), a limbic structure where PACAP and its cognate PAC1 receptors are abundantly expressed. Despite this neuroanatomical evidence, direct functional data supporting a role for septal PACAP/PAC1 receptor signaling in stress regulation are lacking. Using quantitative PCR, we show that forced swim stress increases PACAP mRNA expression in several limbic areas, including the LS, bed nucleus of the stria terminalis and basolateral amygdala, while chronic variable mild stress reduced PACAP expression in the LS only. Providing functional evidence of a PACAP/stress interaction, local administration of PACAP38 into the LS potentiated stress-induced ACTH release and altered stress-coping behavior by increasing passive (floating) and reducing active (struggling) coping during a forced swim challenge. Moreover, intraseptal PACAP38 administration significantly increased anxiety-like behavior in the elevated plus-maze and reduced grooming behavior in the sucrose splashtest, indicating anxiogenic and motivationally disruptive effects following enhanced PACAP signaling in the LS. Importantly, to assess the contribution of endogenous PACAP signaling, intra-LS administration of the PACAP receptor antagonist PACAP(6-38) produced a robust anxiolytic phenotype in the elevated plus-maze. Collectively, these findings provide the first direct evidence that PACAP/PAC1 receptor signaling in the LS modulates emotional and motivational processes in response to stress, identifying this system as a potential target for neuromodulatory interventions in stress-related psychiatric disorders.

Authors

Institutions

Publication Details

Journal
Neuropsychopharmacology
Published
2026-04-21
DOI
https://doi.org/10.1038/s41386-026-02409-y
Primary Topic
Neuropeptides and Animal Physiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lateral septal PACAP signaling regulates stress and anxiety reactions

Jens Hannibal, Magali Basille, Veronica Fontebasso, Nicolas Singewald et al.
Neuropsychopharmacology
Neuropeptides and Animal Physiology
article

Lateral septal PACAP signaling regulates stress and anxiety reactions

Jens Hannibal, Magali Basille, Veronica Fontebasso, Nicolas Singewald, Karl Ebner, Federico Ferro, David Vaudry
article en

Abstract

Severe and/or repeated stress exposure can lead to a number of maladaptive physiological and behavioral changes that contribute to psychiatric illnesses. Recent work indicates that the neuropeptide pituitary-adenylate-cyclase-activating-polypeptide (PACAP) plays an important role in stress-related psychopathologies relevant to depression and trauma-related disorders such as PTSD. However, the specific neural circuits that mediate PACAP effects on stress function are not fully understood. One candidate area is the lateral septum (LS), a limbic structure where PACAP and its cognate PAC1 receptors are abundantly expressed. Despite this neuroanatomical evidence, direct functional data supporting a role for septal PACAP/PAC1 receptor signaling in stress regulation are lacking. Using quantitative PCR, we show that forced swim stress increases PACAP mRNA expression in several limbic areas, including the LS, bed nucleus of the stria terminalis and basolateral amygdala, while chronic variable mild stress reduced PACAP expression in the LS only. Providing functional evidence of a PACAP/stress interaction, local administration of PACAP38 into the LS potentiated stress-induced ACTH release and altered stress-coping behavior by increasing passive (floating) and reducing active (struggling) coping during a forced swim challenge. Moreover, intraseptal PACAP38 administration significantly increased anxiety-like behavior in the elevated plus-maze and reduced grooming behavior in the sucrose splashtest, indicating anxiogenic and motivationally disruptive effects following enhanced PACAP signaling in the LS. Importantly, to assess the contribution of endogenous PACAP signaling, intra-LS administration of the PACAP receptor antagonist PACAP(6-38) produced a robust anxiolytic phenotype in the elevated plus-maze. Collectively, these findings provide the first direct evidence that PACAP/PAC1 receptor signaling in the LS modulates emotional and motivational processes in response to stress, identifying this system as a potential target for neuromodulatory interventions in stress-related psychiatric disorders.

Neuropsychopharmacology
University of Copenhagen (DK), Inserm (FR), Universität Innsbruck (AT), Frederiksberg Hospital (DK), Différenciation et Communication Neuronale et Neuroendocrine (FR), Institute for Research and Innovation in Biomedicine (FR), Université de Rouen Normandie (FR)
Austrian Science Fund
Good health and well-being
Openalex Percentile: Top 12%
Neuropeptides and Animal Physiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.